Edge Capital Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.03M | Buy |
58,465
+635
| +1% | +$54.6K | 0.22% | 85 |
|
|
2024
Q3 | $6.89M | Sell |
57,830
-1,539
| -3% | -$183K | 0.31% | 71 |
|
|
2024
Q2 | $8.47M | Sell |
59,369
-12,447
| -17% | -$1.78M | 0.41% | 59 |
|
|
2024
Q1 | $9.22M | Sell |
71,816
-2,268
| -3% | -$291K | 0.46% | 51 |
|
|
2023
Q4 | $7.66M | Sell |
74,084
-340
| -0.5% | -$35.2K | 0.43% | 51 |
|
|
2023
Q3 | $6.77M | Sell |
74,424
-872
| -1% | -$79.3K | 0.44% | 54 |
|
|
2023
Q2 | $6.09M | Sell |
75,296
-1,922
| -2% | -$156K | 0.35% | 66 |
|
|
2023
Q1 | $6.14M | Sell |
77,218
-7,456
| -9% | -$593K | 0.38% | 60 |
|
|
2022
Q4 | $5.73M | Sell |
84,674
-1,148
| -1% | -$77.7K | 0.4% | 60 |
|
|
2022
Q3 | $4.28M | Buy |
85,822
+218
| +0.3% | +$10.9K | 0.35% | 64 |
|
|
2022
Q2 | $4.77M | Buy |
85,604
+368
| +0.4% | +$20.5K | 0.41% | 55 |
|
|
2022
Q1 | $4.73M | Sell |
85,236
-3,200
| -4% | -$178K | 0.32% | 70 |
|
|
2021
Q4 | $4.95M | Sell |
88,436
-9,530
| -10% | -$534K | 0.35% | 64 |
|
|
2021
Q3 | $4.7M | Sell |
97,966
-48,900
| -33% | -$2.35M | 0.37% | 61 |
|
|
2021
Q2 | $6.15M | Sell |
146,866
-1,020
| -0.7% | -$42.7K | 0.49% | 47 |
|
|
2021
Q1 | $4.99M | Buy |
147,886
+1,444
| +1% | +$48.7K | 0.42% | 58 |
|
|
2020
Q4 | $5.11M | Sell |
146,442
-9,358
| -6% | -$327K | 0.43% | 55 |
|
|
2020
Q3 | $5.41M | Buy |
155,800
+38
| +0% | +$1.32K | 0.54% | 42 |
|
|
2020
Q2 | $5.1M | Sell |
155,762
-36,814
| -19% | -$1.21M | 0.53% | 47 |
|
|
2020
Q1 | $5.8M | Buy |
192,576
+27,208
| +16% | +$819K | 0.69% | 43 |
|
|
2019
Q4 | $4.79M | Buy |
+165,368
| New | +$4.79M | 0.47% | 54 |
|